INTRODUCTION
This review on the serology of parasitic diseases summarizes recent developments in and the present status of the field. Topics included are antibody detection, antigen detection, use of monoclonal antibodies (MAbs) in serodiagnosis, molecular biological technology, and skin tests. A survey of the literature from January 1985 to March 1990 was prepared, but some older references to the use of MAbs and molecular biological technology are included.
Except for the reference serum samples for toxoplasmosis, international standards for serologic antigens and antisera for parasitic diseases have not been developed. In published reports about the specificity of new assays, the studies frequently do not include adequate batteries of sera. Therefore, one cannot compare assays adequately from reports in the literature. Furthermore, the number of commercial laboratories offering serodiagnosis of parasitic diseases and the number of kits on the market are increasing. For these reasons, a specific assay cannot be recommended for each disease. However, this review will emphasize to the reader the need for requesting data about the sensitivities and specificities of the available assays for diagnosing parasitic infections to determine the best tests available.
The basic serodiagnostic tests, such as indirect hemagglutination, whole protozoan or antigen-coated particle agglutination, indirect immunofluorescence (11F), radioimmunoassay, plate enzyme-linked immunosorbent assay (ELISA) with relatively crude antigens, and dot blot assays, continue to be used. Antigen detection in sera and body fluids is being more widely investigated. Recent advances in immunochemistry and molecular biology are resulting in assays of markedly improved sensitivity and specificity. This new technology is costly and not readily available in many lesserdeveloped countries in which most parasitic diseases occur (2) . It is, therefore, of great importance that some approaches are being made to modify techniques to allow their use in field, epidemiologic, and chemotherapeutic studies.
ANTIBODY DETECTION Applicability For parasitic diseases for which parasitological proof of infection is difficult to obtain, serology with a sensitive and specific assay is a very helpful aid to diagnosis for the clinician. At the other end of the spectrum, serology is not indicated in those intestinal helminthic diseases in which parasite eggs are readily detected in fecal specimens. Table  1 lists parasitic diseases according to the usefulness of serologic diagnosis. Nonetheless, while not useful as a diagnostic tool for some parasitic diseases, serology may play an important role in epidemiologic and chemotherapeutic studies of these diseases. This is exemplified by the large number of reports directed to defining meaningful seroepidemiologic assays for malaria. These reports are discussed below in the section on recombinant antigens.
Availability of Commercial Products
Displays of commercial products at immunology and microbiology conferences indicate that a number of serologic kits are available for some parasitic diseases such as amebiasis and toxoplasmosis. In the United States, approval from the Food and Drug Administration (510K) is required to sell diagnostic kits. Unfortunately, a list of the approved (42, 48) .
Test Evaluation
Clinicians frequently have difficulty interpreting serologic data when the fundamental characteristics of the assay (significant diagnostic level of reactivity, sensitivity, and specificity) are not included in the report. The quality of the assay depends not only on the quality of the antigen but also on the selection of sera used to evaluate a new diagnostic procedure. Since no serologic assay is 100% sensitive and specific, a new diagnostic assay should not be evaluated against a previously used procedure. Instead, well-characterized batteries of serum specimens from parasitologically proven cases of homologous and other parasitic infections and from nonparasitic diseases which could present as CLIN. MICROBIOL (28) . Interpretation of the data depends on the levels of reactivity of the serum specimen in IIF for IgG and in capture enzyme immunosorbent assay for IgM antibodies (Table 2) .
FAST-ELISA (schistosomiasis, malaria, fascioliasis, and leishmaniasis). The newer techniques of FAST-ELISA (36) and immunoblot (Western blot) (97) (40) and leishmaniasis (106) . Immunoblot Subclass and Specificity of Response Recently, the relationship between the class of immunoglobulins or subclass of IgG and the specificity of response to parasitic infections has been recognized. As a result, improved serodiagnosis has been reported in toxoplasmosis, several filarial diseases, strongyloidiasis, and hydatidosis, as discussed below.
Toxoplasmosis. The capture IgM ELISA (28) is a technically simple assay for identifying acute and congenital cases of toxoplasmosis, as discussed above. A double-sandwich ELISA for detecting specific IgM antibody (DS-IgM-ELISA) was developed for toxoplasmosis (82) and has a wide application. A single dilution of serum is tested in triplicate, and the level of reactivity is determined from a calibration curve constructed from positive and negative sera, the same principle as FAST-ELISA (36) . These steps resulted in increased reproducibility. The DS-IgM-ELISA allowed differentiation of early-and late-stage infections with Toxoplasma gondii. Recently, a DS-IgA-ELISA, performed in a similar way, also differentiated acute from chronic disease in patients with toxoplasmosis (89) . Specific IgA class antibodies were demonstrated in eight of nine congenitally infected fetuses and in acute but not chronic infection in adults. IgM class antibodies could not be detected in some of these specimens. Only 1 of 20 AIDS patients with biopsy-proven toxoplasmic encephalitis was positive. The authors recommended that tests for IgA antibody be included in assays for toxoplasmosis in pregnant women and congenitally acquired infections in the newborn when the disease is suspected.
Bancroftian filariasis. In bancroftian filariasis, clinical manifestations of the disease correlated with antibody subclass recognition of antigens of different molecular weights (44) . Microfilaremic patients showed stronger IgG4 reactivity in immunoblot to antigens with molecular masses of >68 kDa than did patients with chronic lymphatic pathology. The latter group had little IgG4 reactivity to any antigens. In a plate ELISA the use of a peroxidase-labelled anti-IgG4 conjugant eliminated the nonspecific cross-reactivity with phosphocholine, which is a widely occurring molecule in filarids (52) . Initial studies with two recombinant DNA Brugia malayi antigens indicated differential recognition of these antigens by IgG and IgE classes (104) . Studies of the IgG isotypes remain to be performed.
Onchocerciasis. The IgM class and IgG isotype responses to Onchocerca volvulus antigens of patients with generalized manifestations of onchocerciasis and of others with Sowda were investigated in immunoblots (8) . Responses of all patients were essentially similar except that the Sowda patients had a very marked IgG3 response to two major antigens with apparent molecular masses of 72 and 9 kDa, respectively. The reaction with the 9-kDa antigen was detected more consistently than that with the 72-kDa antigen. The IgG4 response resembled that of total IgG and showed cross-reactivity in the sera of patients with generalized onchocerciasis, bancroftian and Malayan filariasis, and, to a lesser extent, with Mansonella ozzardi and other helminthic infections. Subsequently, this group of investigators used low-molecular-mass (16.2-and 12.8-kDa) antigens from the surface of 0. volvulus adult worms (9) in direct-plate ELISA and an inhibition plate ELISA. In the latter, a MAb recognizing 15.6-and 25.9-kDa 0. volvulus antigens was used to study the same sera in the report discussed above. ELISA using the low-molecular-weight antigen fraction and antiIgG4 conjugate as well as the MAb inhibition ELISA improved specificity of the detection of 0. volvulus infection. However, cross-reactivity with bancroftian filariasis and, to a lesser content, M. ozzardi infection remained.
Strongyloidiasis. Detection of IgG4 reactivity in ELISA also resulted in improved sensitivity of the assay for Strongyloides stercoralis infection (32), in both uncomplicated infections and, to a lesser extent, immunocompromised patients with strongyloidiasis.
Hydatidosis. When crude preparation of hydatid cyst fluid was used as antigen in plate ELISA, detection of IgE class antibodies in patients with hydatidosis resulted in high test sensitivity (85) . When evaluated with serum from 78 patients with other parasitic infections, the specificity was 81%. However, 11 of the 15 patients with false-positive reactions had markedly elevated total IgE levels.
ANTIGEN DETECTION Because antibody usually persists for a year or more after the acute phase of parasitic diseases, demonstration of antibody rarely can differentiate between acute and chronic infection. For the same reason, measurement of antibody levels before and after chemotherapy gives little or no indication of treatment efficacy. Measurement of circulating parasitic antigen or antigen in urine or feces would more appropriately indicate the presence of active infection and, furthermore, might indicate parasite load. In other instances, demonstration of specific parasite antigen in lesion fluid, such as amebic liver abscess "pus" or fluid from a hydatid cyst, would provide definitive diagnosis of the infecting organism.
The literature up to 1984 on the detection of antigens in serum samples and other body products for diagnosing parasitic diseases in humans has been reviewed recently (58) . Eighty-seven additional reports identified from January 1985 to May 1990 are grouped in Table 3 by disease and type of specimen examined. The types of assays used in these studies are shown in Table 4 . Since 1984, there has been a pronounced shift away from radioimmune assays that use isotopes to ELISAs. Not all 87 reports are referenced in this review, but to summarize developments in antigen detection, reports on diseases for which a number of studies were made are discussed below. Amebiasis Use of a sandwich ELISA to detect Entamoeba histolytica antigen in amebic liver abscess pus showed promise, with sensitivity and specificity of 93 and 94%, respectively (1). By using blot ELISA, the need to concentrate serum by precipitation with polyethylene glycol prior to detection of circulating antigen-antibody complexes was eliminated (33) . The test was positive for 75% of 47 patients with amebic liver abscess. In a radioimmunoassay which detected immunologically bound, but not free, amebic antigen, all 10 patients with amebic liver abscess had detectable circulating immune complexes (65) . However, only 79% of 24 patients who were stool positive for E. hystolytica had circulating amebic immune complexes.
Examining stool specimens for amebiasis is unreliable unless done by technicians skilled in recognizing intestinal protozoa. An alternative is a specific assay for detecting amination (69). The investigators also conclude that the antigen detection assay was easier to perform than microscopic examination. Antisera directed against G. lamblia cysts were used in an ELISA to detect antigen in stool eluates (91) . Antigen could be demonstrated in both formalinized and unfixed stool specimens. Changes in antigen levels were useful in monitoring the effect of chemotherapy for giardiasis. A MAb was subsequently developed against G. lamblia cysts for an antigen capture test (90) . The sensitivity of the resulting ELISA was 97% with formalinized stools, but it dropped to 82% with unfixed specimens. The assays appear to be specific for Giardia spp. Studies of the capture antigen indicated that it was heat stable, periodate resistant, and probably a carbohydrate occurring in multiple molecular weights.
Malaria
The level of sensitivity for detecting circulating antigen in malaria correlated with a 0.001% level of parasitemia regardless of whether conventional plate ELISA (27) or dot blot (57) was used. Trials are under way for the use of dot blot in malaria field studies. Double-sandwich dot blotting of unconcentrated urine was positive in 91% of 45 patients infected with Plasmodium falciparum and in 86% of 35 patients infected with P. vivax (49) . However, the levels of parasitemia were not given.
antigen in fecal specimens. One assay that used a MAb for capture and a rabbit anti-E. histolytica polyclonal antibody for a probe in an ELISA was 82% sensitive when used to test 22 stools from patients known to be positive for E. histolytica (99 (84) . Patients' sera competed with peroxidase-labeled leishmania antigen for reactivity VOL. 4, 1991 on January 11, 2018 by guest http://cmr.asm.org/ Downloaded from with hyperimmune serum preabsorbed to ELISA plates. This initial study detected circulating antigen in 100% of 20 parasitologically proven cases of kala azar. The assay appeared to be species specific as antigen was not detected in the sera of six patients with cutaneous leishmaniasis. In another study, antigen-specific circulating immune complexes were precipitated with polyethylene glycol and tested in an ELISA (88) . Immune complexes were detected in 100% of 27 parasitologically proven cases of kala azar, 64% of clinically diagnosed cases, 59% of treated cases, and 5% of healthy controls. The author concluded that the assay was potentially useful for monitoring the effect of chemotherapy.
Hydatidosis
Echinococcal antibodies were found in serum samples from only 25 to 40% of Turkana patients with hydatidosis (15) . However, specific immune complexes in serum specimens from five of seven antibody-negative patients indicated that antigens were complexing with and masking antibody in the serum. This study also indicated that specific IgM immune complexes were associated with active infection.
Cysticercosis (Cerebral)
Although the diagnosis of cerebral cysticercosis has been markedly improved by the introduction of computerized tomography and magnetic resonance imaging, demonstration of specific Taenia solium antigen in cerebrospinal fluid would be a useful adjunct. Two antigens with apparent molecular masses of 190 and 230 kDa were demonstrated in the cerebrospinal fluid of 14 of 18 patients with suspected neurocysticercosis (24) . Nine of these cases were confirmed by histopathology.
Bancroftian Filariasis A comparatively large number of studies report detection of antigen in serum specimens, urine, or hydrocoele fluid in bancroftian filariasis, because it is difficult to obtain a parasitologic diagnosis of the chronic lymphatic form of the disease. Indian investigators have been particularly active in this field, using a B. malayi-specific rabbit antibody in an immunoradiometric assay (73) . Urine and finger prick blood specimens collected on filter paper were found to be suitable for antigen detection in patients with microfilaremia; specimens from patients with chronic infections were negative. However, in another study, circulating antigen was found in 60% of serum samples from amicrofilaremic patients with manifestations of obstructive lymphatic filariasis (43) .
A MAb-based ELISA for detection of circulating Wuchereria bancrofti antigen was more sensitive than detection of microfilariae in patients with active infection (103) . In addition, unlike microfilarial counts, levels of circulating antigen did not fluctuate between night and day, and the assay was useful in monitoring the effects of chemotherapy. When finger prick blood specimens were used in this assay, whole blood samples were satisfactory, but use of specimens dried on filter paper resulted in reduced test sensitivity (80) . To establish microfilarial prevalence rates and levels in an endemic area, the authors suggested that the assay for antigenemia using whole blood collected during the day be used as a screen. All positive reactors should then be bled at night for microfilarial counts. In a hyperendemic area in Mexico, an antigen detection ELISA for 0. volvulus showed correlation between microfilaria levels observed in skin snips and antigen levels detected in serum and urine (81) . It has not yet been determined whether the circulating antigens are associated with both microfilariae and adult worms. Toxocariasis By using a MAb, an ELISA for Toxocara canis circulating antigen differentiated between T. canis and T. cati infections in mice (77) . In a small study of human infections, these investigators detected antigen in some sera from patients with visceral larva migrans or ocular toxocariasis. The assay is being fully evaluated.
Schistosomiasis
The most widely recognized and studied circulating antigens in human and murine infection with S. mansoni are the circulating cathodic antigen and the circulating anodic antigen (CAA) (18) . These polysaccharides are gut associated in adult S. mansoni worms. Circulating cathodic antigen shared some characteristics with the phenol sulfuric test active peak antigen but was shown to differ in comparative studies with MAbs (68). With similar techniques, CAA and the gutassociated proteoglycan were shown to be identical. The level of CAA correlated well with egg counts in feces (21) and showed a rapid drop within 10 days of chemotherapy with praziquantel (19) . In addition, CAA was detected in the urine of 81% of patients with S. mansoni intestinal infections and 97% of patients with S. haematobium urinary infections (20) . S. haematobium egg counts ranged from 5 to 3,000 eggs per 10 ml of urine. However, urine had to be concentrated fivefold and dialyzed before antigen testing. The assay would, therefore, be of greater practical value in epidemiologic and chemotherapeutic studies of S. mansoni infections than S. haematobium infections. However, the use of a homologous antigen might increase the sensitivity of the assay for schistosomiasis haematobium and eliminate the cumbersome urine concentration procedures. Detection of CAA in ELISA by using MAbs was reported (17) . A second, stable, gut-associated polysaccharide has been detected in the urine of patients infected with S. mansoni or S. haematobium (76) . This polysaccharide, however, differs from those described above (68) in that, in addition to being gut associated in adult worms, it also occurs in large amounts in Schistosoma eggs. Antigen in urine was demonstrated by a hemagglutination inhibition assay. Erythrocytes were sensitized with an egg extract antigen. Concentrated urine samples and diluted MAb were allowed to react in a microtiter plate for 30 min before the sensitized cells were added. As counts of S. mansoni and S. haematobium eggs were not recorded in this study, the intensity of infection was not indicated. Antigen was detected in the urine of 57% of patients passing S. mansoni eggs in their stools and in 47% of patients passing S. haematobium eggs in their urine. Antigen was not demonstrable in 200 urine samples from individuals who had never been in an area endemic for schistosomiasis.
USE OF MAbs IN SERODIAGNOSIS
MAbs have been produced against antigens from most parasites known to be pathogenic to humans. The production of most MAbs has involved fusion of antigen-stimulated mouse cells with a mouse myeloma cell line. Recently, Epstein-Barr virus-activated B cells from S. mansoni-infected or vaccinated humans were fused with a mousehuman heteromyeloma cell line. The resulting five human MAbs are presently being characterized (35) . Most investigations with MAbs have been directed to studying hostparasite relationships, particularly, malaria and schistosomiasis. Nonetheless, MAbs have been used in three ways to improve serodiagnosis.
Identification and Purification of Antigenic Components
The immunoblot method is used to identify MAbs that react with antigenically important components of crude or partially purified parasitic extracts. The MAbs are then used to construct immunoaffinity columns for purifying the specific antigenic components from parasitic extracts (79) or from the supernatant fluids of cultured parasites. Biochemical and immunochemical characterizations of the purified components are then possible.
By using this approach, two antigens were purified from Leishmania donovani. Their molecular masses were approximately 70 and 72 kDa (46) . When used in a dot blot assay with sera from patients with visceral leishmaniasis, the test sensitivity was 90 and 100%, respectively. The specificity was 98 and 93%, respectively. Cross-reactions were not observed with the sera of patients with cutaneous or mucocutaneous leishmaniasis or Chagas' disease. The assays could readily be standardized by measuring the level of reactivity of a visceral leishmaniasis reference serum pool with each new batch of antigens.
Competitive Inhibition Assays for Antibody
Schistosomiasis. In a competitive inhibition assay, the extent to which a patient's antibody inhibits the reactivity of any MAb with crude parasite antigen is determined in ELISA, radioimmunoassay, or indirect hemagglutination. This type of ELISA, although more cumbersome than the usual serum dilution ELISA, may result in assays with improved specificity. A MAb specific for adult worm S. japonicum antigen was used in a competitive ELISA, using a crude adult worm antigen. Positivity correlated well with the classical circumoval precipitin test, and the assay provided quantitative information important for monitoring the effects of chemotherapy (64) .
Chagas' disease. The above approach has also been successful in the development of an assay for visceral leishmaniasis (45) . An inhibition assay with a MAb against an Mr-25,000 epimastigote antigen of Trypanosoma cruzi was positive with sera from 41 patients with chronic Chagas' disease in Brazil, Paraguay, and Ecuador (94) . No crossreactivity was observed with sera from 5 leishmania patients or 24 patients with other protozoal disease.
In Bolivia, where both Chagas' disease and mucocutaneous leishmaniasis occur, a MAb inhibition assay with a "component 5"-enriched antigen of Trypanosoma cruzi eliminated cross-reactivity of antibody from the leishmania cases (53 (25, 26) or antigen in body fluids or feces (99) . The captured antigen can be detected and quantitated by probing with an enzyme-conjugated, antigen-specific antiserum. If the capture MAb recognizes a repeating epitope on the antigen molecule, the same MAb may be used as the indicator probe. If the epitope does not repeat, a second MAb recognizing a different epitope on the same antigen molecule or a polyvalent antiserum is used as a probe to ensure accessibility to the second epitope site. An alternative is to reduce the size of the probe molecule by preparing F(ab')2 from the antibody used as a probe. If different species of animals are used to produce the capture and indicator immunoglobulins, reduction of the capture antibody to F(ab')2 will eliminate any cross-reactivity between the capture and probe antibodies (51) . Recently developed assays with MAbs as capture antibody for antigenemia include those for bancroftian filariasis (80, 103) , schistosomiasis (17-19, 21, 76) , toxocariasis (77) , amebiasis (99) , and giardiasis (69, 90, 91) . These have been discussed in the preceding section.
MOLECULAR BIOLOGICAL TECHNOLOGY Many molecular studies of parasites pathogenic for humans are directed to mapping the genome and to gene regulation of parasite development stages (83) . Some studies have resulted in production of DNA probes from parasites. When hybridized to DNA from organisms causing human infection, the probes are highly specific diagnostic and epidemiologic tools (105) . This subject has recently been reviewed extensively (4) and will not be discussed here because it is not a serologic technique.
Other molecular biological studies have concentrated on protective antigens (71) and vaccine production (3, 92) . The subject of control of parasitic diseases by vaccines has also been reviewed recently (61) .
Antigen Production (Hybridization) Trypanosoma cruzi and Leishmania mexicana. A new approach to antigen production is the hybridization of viable living parasite cells with mouse myeloma cells. The epimastigotes of T. cruzi were fused with mouse myeloma P3-x63-Ag8 cells. The hybridomas expressed T. cruzi antigen during 14 weeks of serial cultivation (16 Echinococcus multilocularis. A recombinant polypeptide, 11/3, was identified as a potentially sensitive, specific diagnostic antigen for E. multilocularis (101) . By using the immunoblot assay, specific bands of 33 and 31 kDa were identified. In further studies (67) , to obtain a large quantity of purified antigen, a shortened fragment of antigen II/3 encoding cDNA in a plasmid vector was expressed in Escherichia coli. The purified product (antigen 11/3-10) was used in an ELISA. Tests with sera from well-documented cases of alveolar hydatidosis (n = 88), cystic (E. granulosus) hydatidosis (n = 108), 110 patients with other helminthic infections, and 355 Swiss blood donors showed 90% sensitivity and 99% specificity. The authors thus considered antigen 11/3-10 to be a potentially useful serodiagnostic antigen.
A second team of investigators (38) produced two recombinant E. multilocularis antigens, EM2 and EM4. EM2 had an apparent molecular mass of 70 kDa, and EM4 was identified as 62-, 49-, and 144-kDa bands in immunoblot. The native antigens of both clones are present in E. granulosus protoscolices and Taenia solium cysticerci but were not detected in E. granulosus cyst fluid. This may explain the absence of responsiveness of sera from patients with E. granulosus or Taenia solium infections to these cloned antigens.
Schistosoma mansoni. In preliminary studies with infected mouse and human serum specimens, an in vitro translation product, p40, from S. mansoni egg poly(A)+ mRNA (14) and a fusion product of part of a 31/32-kDa S. mansoni adult worm purified antigen (50) showed good serologic activity.
Onchocerca volvulus. A species-specific recombinant antigen derived from adult female worms of 0. volvulus has been isolated (56) . The antigen has an apparent molecular mass of 16 kDa and is a potentially useful serodiagnostic reagent.
Toxocara canis. Examination of in vitro translation products from mRNA of T. canis by immunoprecipitation and sodium dodecyl sulfate-polyacrylamide gel electrophoresis indicated that a 27-kDa polypeptide reacted strongly with a serum specimen from a patient with toxocariasis (93 both Kenya (14) and Gabon (13) . Three synthetic peptides derived from ring-infected erythrocyte surface antigens were tested in parallel with the CS synthetic peptide in an endemic area (10) . Recombinant antigens F2-CAT and M6-DHFR derived from merozoites of P. falciparum were used to study patients with acute symptoms of malaria presenting at a hospital in Germany after travel in Africa. ELISA plates were sensitized with F2-CAT and M6-DHFR and reacted with patients' sera. To avoid reaction of the sera with bacterial antigenic components in these merozoite recombinant antigens, aliquots of the antigens were fused to ,-galactosidase. Specific antibodies in the sera reacted with and bridged the F2-CAT/M6-DHFR-adsorbed antigens and the ,B-galactosidase fusion antigens. Enzyme activity of the ,-galactosidase indicated positive reactions. The resulting P-galactosidase bridge ELISA appeared to be sensitive, with very little background activity. Recombinant P. falciparum peptides were compared in ELISA by using sera of individuals living in The Gambia. A mixture of the three peptides, (i) a conserved portion of the 190-to 200-kDa schizont merozoite component, (ii) the carboxy-terminal part of P. falciparum aldolase, and (iii) the 5.1 antigen, derived from the erythrocyte stage and having one or more epitopes cross-reactive with the CS protein, showed the highest sensitivity (87) . The assay is potentially suitable for detection of antimalarial antibodies directed against asexual blood stages of the parasites in children as well as in adults.
The dynamics of antibody responses in children living in a mesoendemic area for P. falciparum in Gabon was studied (12) . The three antigens used were (i) the synthetic peptide (NANP)40 representing the CS antigen, (ii) the fusion protein 31.1 representing the 190-to 200-kDa glycoprotein of merozoites, and (iii) a mixture of infected fixed erythrocytes for the surface antigen (ring-infected erythrocyte surface anti-CLIN. MICROBIOL. REV.
on January 11, 2018 by guest http://cmr.asm.org/ Downloaded from gen) and unfixed infected erythrocytes for the intraerythrocytic asexual form antigen. The first two antigens were used in ELISA and the third was used in IIF. In infants up to 2 months of age, the percentages with antibodies against the intraerythrocytic asexual form, (NANP)40, and 31.1 antigens were 50, 26, and 21%, respectively. This represents passively transferred maternal antibody. No anti-ring-infected erythrocyte surface antigen antibodies were detected. A decrease in antibody levels occurred between the ages of 2 and 65 months and thereafter increased progressively. By 15 years of age, the levels of antibodies were approaching those of adults. However, antibodies to the intraerythrocytic asexual form antigen developed earlier than did those to (NANP)40.
Trypanosoma cruzi. A recombinant antigen, associated with trypomastigotes but not epimastigotes of T. cruzi, was recognized by sera from patients with acute Chagas' disease (29) . A second fusion antigen was recognized by sera from patients with chronic Chagas' disease. Neither antigen cross-reacted with sera from patients with leishmaniasis. If further studies confirm these observations, a useful serologic test for distinguishing the two stages of Chagas' disease would be available.
SKIN TESTS
For some diseases, parasitologic diagnosis is rarely possible without biopsy or surgery, and skin tests have been recognized as simple inexpensive aids to diagnosis. An example of an immediate hypersensitivity reaction was a positive Casoni test for hydatidosis. The antigen was crude hydatid fluid. Delayed hypersensitivity reactions to leishmanin antigen (whole promastigotes of L. donovani) occurred in patients whose Montenegro tests were positive for visceral leishmaniasis. However, several problems have been associated with skin tests for parasitic diseases. Reference standards for skin test antigens and for performance, including reading, of the tests have not been developed. Most antigens are crude extracts of parasites and are neither highly sensitive nor specific. The danger of provoking anaphylaxis by injecting skin test antigen, particularly in patients with helminthiases, must be considered. Skin tests may also induce serologically detectable antibody which could complicate subsequent serologic evaluation of a patient. More recently, the ethics of injecting foreign protein antigen into an individual, particularly in epidemiologic studies, has been questioned.
In the United States, no parasite skin test antigens have been available commercially or from the CDC for the past 5 years. It has not been possible to determine which parasite skin test antigens are available commercially or from reference centers in Europe or Asia.
Toxoplasmosis
In the 4-year survey conducted for this review, several interesting reports of progress in the area of toxoplasmosis diagnosis were identified. An approach to a standardized skin test was clearly defined for detecting T. gondii infection in women before they become pregnant (78) . An excretorysecretory antigen was prepared in accordance with biologic safety standards and delivered with a multipuncture ring. Optimal reading to avoid false-positive reactions was at day 7. The authors concluded that skin testing could play an important role in the prevention of congenital toxoplasmoSiS.
Leishmaniasis
A crude extract of cultured L. donovani chagasi promastigotes was substituted for whole promastigotes in a leishmania skin test antigen widely used in South America (74) . Reactions were observed in 97% of persons with a 2-year history of visceral leishmaniasis. Cross-reactivity occurred at a low level (8%) in patients with Chagas' disease, but not in patients with other diseases. In contrast, extracts of promastigotes were insensitive as skin test antigens in two other studies in South America. Whole promastigote antigen was also found to be insensitive in Egypt (66) and Brazil (102) . In India, skin test positivity to whole promastigote antigen was not demonstrable until 5 months after the acute phase of visceral leishmaniasis (70) . At this time the positivity rate was 20%, and it increased to 86.6% after 8 months. A fusion protein derived by molecular expression cloning of an African strain of L. donovani was found to be highly sensitive and specific for visceral leishmaniasis (5) . The authors suggested it as a putative skin test antigen.
Hydatidosis
Reports of Casoni tests for hydatidosis came from India (60), People's Republic of China (63), and Saudi Arabia (72) . The sensitivity varied from 58 to 86%. False-positive reactions were observed in the Indian study; specificity data were not included in the other studies.
CONCLUSIONS
Kits for antibody detection in some parasitic diseases are available commercially in the United States, South America, Europe, and Asia, but lists of these kits are unavailable. Similarly, a number of commercial laboratories in various countries perform serodiagnosis for parasitic diseases, but it is not possible to obtain lists of these laboratories. Because international or national standard reference antigens and antisera have not been developed, and because the batteries of homologous and potentially cross-reactive serum specimens used to evaluate assays often have been inadequate, it is impossible to compare serologic assays and recommend a particular one for a particular disease. These deficits in parasitic serology apply equally to kits for antigen and antibody detection and to quality control programs with laboratories.
The need for assays that would be applicable to field, epidemiologic, and chemotherapeutic studies in tropical countries, where most of the human parasitic diseases occur, is important. Technically, both FAST-ELISA and immunoblot with prepared antigen strips can be used for such studies. However, the main drawback is the unavailability of adequate amounts of appropriate affordable antigens. The finding that finger prick blood samples can be collected in capillary tubes and stored in buffer or preservative without refrigeration is a major step forward. More than one capillary tube of blood could be collected from each individual with well-documented disease, which could thus form the basis of much needed blood (antibody) collections for evaluation of sensitivity and specificity of new antigens and assays. The reluctance to perform venipuncture and the cost of expensive syringes would be bypassed.
Skin testing is playing a markedly diminished role in the diagnosis of parasitic infections. A number of reasons include lack of reference standards, lack of sensitivity and specificity, and the danger of provoking anaphylaxis. 
